Intrapleural BCG in operable lung cancer.
In a controlled randomised clinical trial of 92 patients with surgically resected lung cancer, intrapleural BCG had no clear effect on survival. Adverse effects were insignificant.
D000230:Adenocarcinoma / Q000601:surgery / Q000628:therapy; D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000601:surgery / Q000628:therapy; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000601:surgery / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000601:surgery / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D009367:Neoplasm Staging; D010994:Pleura; D011182:Postoperative Care
D001500:BCG Vaccine